Paris, France

Claude Fromentin

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 4.0

ph-index = 11

Forward Citations = 373(Granted Patents)


Location History:

  • de Flandres, FR (1998)
  • Paris, FR (1995 - 2012)

Company Filing History:


Years Active: 1995-2012

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Claude Fromentin: Innovator in Medicinal Chemistry

Introduction

Claude Fromentin is a distinguished inventor based in Paris, France. He has made significant contributions to the field of medicinal chemistry, particularly through his work on heterocyclic compounds. With a total of 14 patents to his name, Fromentin has established himself as a key figure in the development of new therapeutic agents.

Latest Patents

Among his latest patents, Fromentin has focused on heterocyclic compounds, their preparation, and their use as medicaments, especially as anti-bacterial agents. The invention relates to new heterocyclic compounds of general formula (I) and their salts with a base or an acid. Additionally, the invention encompasses a process for the preparation of these compounds, highlighting their potential use as effective medicaments.

Career Highlights

Fromentin has had a notable career, working with prominent companies in the pharmaceutical industry. He has been associated with Aventis Pharma S.A. and Roussel Uclaf, where he contributed to various innovative projects. His expertise in medicinal chemistry has been instrumental in advancing the development of new drugs.

Collaborations

Throughout his career, Fromentin has collaborated with several talented individuals, including Alexis Denis and Constantin Agouridas. These collaborations have further enriched his work and contributed to the success of his inventions.

Conclusion

Claude Fromentin's contributions to the field of medicinal chemistry through his patents and collaborations have made a significant impact on the development of new therapeutic agents. His work continues to inspire innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…